Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-06-05
1988-04-05
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514363, 514365, 514372, 514383, 548262, 548250, 548146, 548214, 548336, A61K 31425, A61K 3141
Patent
active
047359609
ABSTRACT:
This invention provides a method of inhibiting aromatase and treating estrogen-dependent diseases in mammals by administering certain azole derivatives. Certain azole derivatives and their pharmaceutical formulations are also provided.
REFERENCES:
patent: 3709901 (1973-01-01), Draber et al.
patent: 3764690 (1973-10-01), Draber et al.
patent: 3794653 (1974-02-01), Draber et al.
patent: 3801590 (1974-04-01), Draber et al.
patent: 3852056 (1974-12-01), Draber et al.
patent: 3897438 (1975-07-01), Draber et al.
patent: 3941800 (1976-03-01), Draber et al.
patent: 4602025 (1986-07-01), Hirsch et al.
Draber et al. (IV); CA76:59632e (1972) N-(1,1,1-trisubstituted) methylazoles.
Sumitomo I (CA:95:203952w), 1981.
Humburg et al., "1,5-Disubstituierte 1,2,4-triazolverbindungen", Liebigs Ann. Chem., 1387 (1982).
Chemical Abstracts 95:203952w (1981).
Chemical Abstracts 96:68990k (1982).
Hirsch Kenneth S.
Jones Charles D.
Taylor Harold M.
Conrad Robert A.
Dinner D. L.
Eli Lilly and Company
Raymond Richard L.
Whitaker Leroy
LandOfFree
Aromatase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aromatase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aromatase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2233865